leisure time -WSS

leisure time

author：fashion 2025-09-30 23:40:06 - browse：9

Blue CAR-T cell attacks a leukemia cell. --health coverage from STAT — Engineered receptors on the surface of a T-lymphocyte bind to a leukemia cell. Adobe

The announcement on Tuesday that the Food and Drug Administration was investigating whether CAR-T immunotherapy had itself caused blood cancers initially appeared to be a significant blow to one of the brightest spots in cancer care.

But experts quickly cautioned that risk of this complication is probably minuscule compared to the known risk of secondary cancers from other cancer therapies like chemotherapy and radiation. They noted that CAR-T cells are immune cells that are genetically engineered to fight cancer, and that such genetic modifications were long thought to carry a risk of causing a second, new cancer in patients. The surprise, in a way, is that since CAR-T was first invented more than 10 years ago, that risk had remained just theoretical.

“There’s been a requirement for long-term follow up. I think this is why we’re all surprised. As far as I think any one of us knew, it’d never happened with any of the FDA-approved CAR-Ts,” said Marcela Maus, a cell therapy researcher at Mass General Cancer Center.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： Review: 'Barbie' will hit you like a shot in the heart

leisure time

WSS

How artificial intelligence is being used to detect, treat cancer

What is the Wagner Group? The 'brutal' Russian military unit in Ukraine

Body of missing toddler recovered in Delaware River days after flood: Police

The battle over the Brookhaven Landfill on Long Island

Weight bias in eating disorder treatment complicated by new weight loss drugs

In areas with more Black doctors, Black people live longer

explore

leisure time

hotspot

After affirmative action ruling, medical educators look to 'holistic review'

Providers still hesitate to prescribe buprenorphine, study finds

In age of alternative facts, a scholarly course on calling out crap

HIPAA doesn't protect reproductive records from prosecutors

Medical records are filled with copy

FDA grants conditional OK to Sarepta’s gene therapy for Duchenne

Affirmative action in medical school literally saved lives

Why are elite athletes different? Take a look at their microbes

Walensky prepares to leave CDC — and Congress — behind

Obesity experts on risks of Wegovy, Ozempic weight loss drugs

entertainment

Hyaluronic acid injections don’t help knee osteoarthritis, study finds

7 of the most gruesome medical devices in history

CDC backtracks, saying fully vaccinated people can go maskless indoors

Vatican is moving ahead with plan to reunite Ukrainian children taken to Russia with their families

The story of mRNA: From a loose idea to a tool that may help curb Covid

FDA official pushes for dedicated emerging pathogens team

explore

leisure time

focus

hotspot